OA07644A - Dérivés de la pyridazine amino -substitués en position 3, actifs sur le système nerveux central, procédé d'obtention et médicaments en contenant. - Google Patents
Dérivés de la pyridazine amino -substitués en position 3, actifs sur le système nerveux central, procédé d'obtention et médicaments en contenant.Info
- Publication number
- OA07644A OA07644A OA58216A OA58216A OA07644A OA 07644 A OA07644 A OA 07644A OA 58216 A OA58216 A OA 58216A OA 58216 A OA58216 A OA 58216A OA 07644 A OA07644 A OA 07644A
- Authority
- OA
- OAPI
- Prior art keywords
- substituted
- obtaining
- active
- nervous system
- central nervous
- Prior art date
Links
- 210000003169 central nervous system Anatomy 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- LETVJWLLIMJADE-UHFFFAOYSA-N pyridazin-3-amine Chemical class NC1=CC=CN=N1 LETVJWLLIMJADE-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8301234A FR2540113A1 (fr) | 1983-01-27 | 1983-01-27 | Acides derives de la pyridazine actifs sur le systeme nerveux central |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA07644A true OA07644A (fr) | 1985-05-23 |
Family
ID=9285330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA58216A OA07644A (fr) | 1983-01-27 | 1984-01-26 | Dérivés de la pyridazine amino -substitués en position 3, actifs sur le système nerveux central, procédé d'obtention et médicaments en contenant. |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US4721711A (enExample) |
| EP (1) | EP0117779B1 (enExample) |
| JP (1) | JPS59141564A (enExample) |
| KR (1) | KR910000638B1 (enExample) |
| AR (1) | AR240045A1 (enExample) |
| AT (1) | ATE48417T1 (enExample) |
| AU (2) | AU2372984A (enExample) |
| CA (1) | CA1238637A (enExample) |
| DD (1) | DD220026A5 (enExample) |
| DE (1) | DE3480653D1 (enExample) |
| DK (1) | DK162985C (enExample) |
| ES (1) | ES529081A0 (enExample) |
| FI (1) | FI78691C (enExample) |
| FR (1) | FR2540113A1 (enExample) |
| HU (1) | HU193890B (enExample) |
| IE (1) | IE57054B1 (enExample) |
| IL (1) | IL70756A (enExample) |
| MA (1) | MA20018A1 (enExample) |
| NO (1) | NO840313L (enExample) |
| NZ (1) | NZ206945A (enExample) |
| OA (1) | OA07644A (enExample) |
| PH (1) | PH21162A (enExample) |
| PL (1) | PL142340B1 (enExample) |
| PT (1) | PT77993B (enExample) |
| SG (1) | SG93690G (enExample) |
| YU (1) | YU14284A (enExample) |
| ZA (1) | ZA84502B (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2540113A1 (fr) * | 1983-01-27 | 1984-08-03 | Sanofi Sa | Acides derives de la pyridazine actifs sur le systeme nerveux central |
| EP0190563B1 (de) * | 1985-01-14 | 1989-08-02 | Boehringer Ingelheim Kg | Neue 12-Amino-pyridazino[4',5':3,4]pyrrolo-[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung |
| US5082939A (en) * | 1987-01-08 | 1992-01-21 | I.S.F. Societa Per Azioni | Pyridazine derivatives |
| US5106973A (en) * | 1987-11-23 | 1992-04-21 | Janssen Pharmaceutica N.V. | Pyridzainamine derivatives |
| FR2663326B2 (fr) * | 1989-11-17 | 1992-10-16 | Sanofi Sa | Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant. |
| US5631255A (en) * | 1989-02-07 | 1997-05-20 | Sanofi | Pyridazine derivatives |
| FR2668151A1 (fr) * | 1990-10-23 | 1992-04-24 | Rhone Poulenc Agrochimie | Composes a groupe triazolopyridazine leurs preparations et compositions herbicides les contenant. |
| FR2676444B1 (fr) * | 1991-05-16 | 1995-03-10 | Sanofi Elf | Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant. |
| CN1038249C (zh) * | 1991-08-28 | 1998-05-06 | 罗姆和哈斯公司 | 含有二氢哒嗪酮及其相关化合物的杀菌组合物 |
| US20100210590A1 (en) * | 1995-09-27 | 2010-08-19 | Northwestern University | Compositions and treatments for seizure-related disorders |
| US20030176437A1 (en) * | 2001-08-31 | 2003-09-18 | D.M. Watterson | Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death |
| CA2589102C (en) * | 2004-11-02 | 2013-08-13 | Northwestern University | Pyridazine compounds and methods for using the compounds to treat inflammatory diseases |
| MX2007005247A (es) | 2004-11-02 | 2008-03-13 | Univ Northwestern | Compuestos de piridazina, composiciones y metodos. |
| US20100168120A1 (en) * | 2006-04-28 | 2010-07-01 | Neuromedix Inc. | Salts of pyridazine compounds |
| AU2007243280A1 (en) * | 2006-04-28 | 2007-11-08 | Northwestern University | Formulations containing pyridazine compounds for treating neuroinflammatory diseases |
| EP2015750A2 (en) * | 2006-04-28 | 2009-01-21 | Northwestern University | Compositions and treatments using pyridazine compounds and cholinesterase inhibitors |
| CN101668732A (zh) * | 2007-04-02 | 2010-03-10 | 同一世界健康研究院 | Cftr抑制剂化合物及其用途 |
| US8236838B2 (en) * | 2008-04-21 | 2012-08-07 | Institute For Oneworld Health | Compounds, compositions and methods comprising isoxazole derivatives |
| WO2009131947A2 (en) * | 2008-04-21 | 2009-10-29 | Institute For Oneworld Health | Compounds, compositions and methods comprising pyridazine derivatives |
| US20090264433A1 (en) * | 2008-04-21 | 2009-10-22 | Institute For Oneworld Health | Compounds, Compositions and Methods Comprising Triazine Derivatives |
| US8207205B2 (en) * | 2008-04-21 | 2012-06-26 | Institute For Oneworld Health | Compounds, compositions and methods comprising oxadiazole derivatives |
| WO2010033626A1 (en) * | 2008-09-19 | 2010-03-25 | Institute For Oneworld Health | Compounds, compositions and methods comprising imidazole and triazole derivatives |
| US8343976B2 (en) * | 2009-04-20 | 2013-01-01 | Institute For Oneworld Health | Compounds, compositions and methods comprising pyrazole derivatives |
| US20100267706A1 (en) * | 2009-04-20 | 2010-10-21 | Institute For Oneworld Health | Compounds, Compositions and Methods Comprising Pyridazine Derivatives |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2510998B1 (fr) * | 1981-08-07 | 1986-01-10 | Sanofi Sa | Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent |
| FR2510997A1 (fr) * | 1981-08-10 | 1983-02-11 | Sanofi Sa | Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant |
| FR2540113A1 (fr) * | 1983-01-27 | 1984-08-03 | Sanofi Sa | Acides derives de la pyridazine actifs sur le systeme nerveux central |
| US4565814A (en) * | 1983-01-28 | 1986-01-21 | Sanofi | Pyridazine derivatives having a psychotropic action and compositions |
-
1983
- 1983-01-27 FR FR8301234A patent/FR2540113A1/fr active Granted
-
1984
- 1984-01-18 CA CA000445481A patent/CA1238637A/en not_active Expired
- 1984-01-20 PH PH30135A patent/PH21162A/en unknown
- 1984-01-20 AR AR295532A patent/AR240045A1/es active
- 1984-01-23 IL IL70756A patent/IL70756A/xx unknown
- 1984-01-23 IE IE149/84A patent/IE57054B1/en not_active IP Right Cessation
- 1984-01-23 PT PT77993A patent/PT77993B/pt not_active IP Right Cessation
- 1984-01-23 ES ES529081A patent/ES529081A0/es active Granted
- 1984-01-23 ZA ZA84502A patent/ZA84502B/xx unknown
- 1984-01-24 AU AU23729/84A patent/AU2372984A/en not_active Abandoned
- 1984-01-25 AT AT84400156T patent/ATE48417T1/de not_active IP Right Cessation
- 1984-01-25 EP EP84400156A patent/EP0117779B1/fr not_active Expired
- 1984-01-25 DE DE8484400156T patent/DE3480653D1/de not_active Expired - Fee Related
- 1984-01-26 DD DD84259650A patent/DD220026A5/de not_active IP Right Cessation
- 1984-01-26 NZ NZ206945A patent/NZ206945A/en unknown
- 1984-01-26 OA OA58216A patent/OA07644A/xx unknown
- 1984-01-26 NO NO840313A patent/NO840313L/no unknown
- 1984-01-26 KR KR1019840000335A patent/KR910000638B1/ko not_active Expired
- 1984-01-26 MA MA20239A patent/MA20018A1/fr unknown
- 1984-01-26 FI FI840323A patent/FI78691C/fi not_active IP Right Cessation
- 1984-01-26 HU HU84331A patent/HU193890B/hu not_active IP Right Cessation
- 1984-01-27 DK DK038984A patent/DK162985C/da active
- 1984-01-27 YU YU00142/84A patent/YU14284A/xx unknown
- 1984-01-27 PL PL1984245931A patent/PL142340B1/pl unknown
- 1984-01-27 JP JP59013234A patent/JPS59141564A/ja active Pending
-
1985
- 1985-10-03 US US06/783,686 patent/US4721711A/en not_active Expired - Fee Related
-
1988
- 1988-08-18 AU AU21421/88A patent/AU652118B2/en not_active Ceased
-
1990
- 1990-11-19 SG SG936/90A patent/SG93690G/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| OA07644A (fr) | Dérivés de la pyridazine amino -substitués en position 3, actifs sur le système nerveux central, procédé d'obtention et médicaments en contenant. | |
| EP0737700A3 (en) | Release agent containing block copolymer, diamine precursors and processes for their preparation and products made therefrom which contain the release agent | |
| EP0556387A4 (en) | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE 1,3-BUTANEDIOL. | |
| DE3788244D1 (de) | Pharmakologisch wirksame 3-substituierte 1,5-Diaryl-pyrazole und Verfahren zu ihrer Herstellung. | |
| OA07175A (fr) | Nouveaux dérivés de la pyridazine actifs sur le système nerveux central. | |
| DE69013317D1 (de) | Kode-multiplex-vielfachzugriffsystem mit durch teilnehmerstimme aktiviertem träger und kode-synchronisation. | |
| OA06920A (fr) | Halogénures d'ammonium spiro-quartenaire, leur procédé de préparation et leur utilisation dans un procédé de production de N-(2-pyrimidinyl) pipérazinyl-alkylazospiro-alcanédiones. | |
| DE68920061D1 (de) | Hydrofile, feine Gelpartikel und Verfahren zu deren Herstellung. | |
| DE3580875D1 (de) | Pyrimidin-derivate, verfahren zu deren herstellung und diese enthaltende zusammenstellungen. | |
| OA08383A (fr) | Procédé de préparation d'urée. | |
| OA07179A (fr) | Nouveaux dérivés de la pyridazine actifs sur le système nerveux central. | |
| OA08384A (fr) | Procédé de préparation de l'urée. | |
| DE3770661D1 (de) | 1,2,3,4-tetrahydro-6-substituierte-4-aryl(oder heterozyklo)3-((substituierte amino)carbonyl)-2-thioxo(oder oxo)-5-pyrimidinkarbonsaeuren und -ester. | |
| DE3580823D1 (de) | Pyrimidin-derivate, verfahren zu deren herstellung und diese enthaltende zusammenstellungen. | |
| DE3650211D1 (de) | Polyätherhomo- oder -copolymer, Monomer dafür und Verfahren zu deren Herstellung. | |
| DE3767894D1 (de) | 1,2-dithiol-3-thion-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung. | |
| DZ1687A1 (fr) | Procédé d'extraction par membrane. | |
| HUT53774A (en) | Antidotums containing 2,3-substituted 1,8-naphtiridines, antidoted herbicide kompositions and process for producing the active components | |
| FR2504526B1 (fr) | Derives de l'amidine, leur procede de preparation et agents anti-complement en contenant | |
| NL193614B (nl) | Werkwijze voor de bereiding van 4,5-tri- en -tetramethyleen-4-isothiazoline-3-onen, 2-alkyl- of -aralkylthio-1-cycloalkeencarbonamiden ten gebruike bij deze werkwijze en werkwijze voor de bereiding van de 2-alkyl- of -aralkylthio-1-cycloalkeencarbonamiden. | |
| DE3675378D1 (de) | 16,17-acetalsubstituierte pregnan-21-saeure, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate. | |
| FR2666591B1 (fr) | Procede et dispositif de recuperation selective des ions argent en solution, composition eluante de recuperation et utilisation d'une telle composition. | |
| ZA872022B (en) | 2-azolylmethyl-2-aryl-1,3-dioxolanes and the salts thereof,processes for the preparation thereof,agents containing same,and the use thereof | |
| DK642687D0 (da) | N,n'-disubstituerede urinstoffer samt fremgangsmaade til fremstilling deraf | |
| HUT49846A (en) | Process for producing n-(3',4'-dimethoxycinnamoyl)-anthranilic acid (tranilast) |